Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.72EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.43EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.85EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.66 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.72 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.133 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.5.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.43.7 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.33.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.493EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.351.2 (Beta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.640.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.352EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.251EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCJEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FT.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.256NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23594.8US
KN.1.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23604.3China
AY.109 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23619.5US
A.6ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-23621.9Japan
XAY.3ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-23621.9Japan
HN.6SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23698.9Japan
B.1.333NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23778.3US
B.1.338NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23778.3US
B.1.371NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23778.3US
XBB.1.5.48NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XBB.1.5.10NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
EK.2.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XBB.1.5.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XBB.1.5.66NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XBB.1.5.4NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
EG.1.7NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
GS.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.1.258.17NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BA.1.21.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
BA.5.1.37NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XBB.1.39NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
EE.3NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
DV.4NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
ES.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XBB.1.5.41NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XBB.1.19.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.1.479NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.1.1.437NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.1.371NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
B.4.4NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
FY.6.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
HU.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used